AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « included »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
include < included < includes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000015 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000016 (2009) Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000087 (2011) K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne]Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
000088 (2011) Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000089 (2013) Alfredo Adán [Espagne] ; Marina Mesquida [Espagne] ; Victor Llorenç [Espagne] ; Gerard Espinosa [Espagne] ; Blanca Molins [Espagne] ; Maria V. Hernández [Espagne] ; Laura Pelegrín [Espagne]Tocilizumab treatment for refractory uveitis-related cystoid macular edema
000105 (2012) M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-BáezIndirect comparison of biological treatments in refractory rheumatoid arthritis
000130 (2007) Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000189 (2013) Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000221 (2015) Ester G. Penserga [Philippines] ; Therese Aileen L. Natividad [Philippines] ; Evelyn S. Salido [Philippines]Clinical profile of 266 Filipino patients with rheumatoid arthritis included in the rheumatoid arthritis database and registry (RADAR) of the Philippine General Hospital
000240 (2013) Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
000276 (2012) M. G. Braun [Allemagne] ; P. Wagener [Allemagne]Regression von peripheren und pulmonalen Rheumaknoten unter Rituximab-Therapie
000393 (2011) Masahiro Iwamoto [Japon] ; Sumiko Homma [Japon] ; Sachiko Onishi [Japon] ; Yasuyuki Kamata [Japon] ; Katsuya Nagatani [Japon] ; Zentaro Yamagata [Japon] ; Seiji Minota [Japon]Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season
000875 (2012) Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse]A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
000A49 (2009) Khader N. Mustafa [Jordanie] ; Azmy Hadidy [Jordanie] ; Nadera J. Sweiss [États-Unis]Clinical and radiological features of Takayasu’s arteritis patients in Jordan
000A78 (2012) Yayoi Nagai [Japon] ; Michiko Hasegawa [Japon] ; Etsuko Okada [Japon] ; Tomoyasu Hattori [Japon] ; Osamu Tago [Japon] ; Osamu Ishikawa [Japon]Clinical follow‐up study of adult‐onset Still’s disease
000B07 (2013) H. B. Hammer [Norvège]OP0170 The Radiocarpal and MCP2 Joints Should be Included in Ultrasonographic Follow-Up of RA Patients During Biologic Treatment
000B44 (2012) W. Rigby [États-Unis] ; H. Tony [Allemagne] ; K. Oelke [États-Unis] ; B. Combe [France] ; A. Laster [États-Unis] ; C. A. Von Muhlen [Brésil] ; E. Fisheleva [Royaume-Uni] ; C. Martin [Royaume-Uni] ; H. Travers [Royaume-Uni] ; W. Dummer [États-Unis]Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial
000C76 (2011) P. Willeke [Allemagne] ; H. Becker [Allemagne] ; S. Wassenberg [Allemagne] ; H. Pavenst Dt [Allemagne] ; A. M. Jacobi [Allemagne]Bewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen
000C86 (2013) Goohyeon Hong [Corée du Sud] ; Hojoong Kim [Corée du Sud, États-Unis]Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement
000C87 (2013) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Kakunoshin Yoshida [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Hip score and disease activity correlation in patients with rheumatoid arthritis after total hip arthroplasty
000C95 (2011) Kamal Esalatmanesh [Iran] ; Raika Jamali [Iran] ; Arsia Jamali [Iran] ; Bardia Jamali [Iran] ; Mohammadreza Nikbakht [Iran]Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "included" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "included" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    included
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021